This report considers the implications of the adoption of EC Regulation 1924/2006. In addition to summarizing the results of the new legislation, the report examines what options now face manufacturers in this sector, what strategies can be employed to navigate the new regulations, and what opportunities have emerged due to the changing regulatory environment. For many ingredients left without a health claim, there is no other option than to generate new data through clinical trials.

For the full report, please visit http://www.datamonitorconsumer.com/health-claim-strategies-for-food-and-drinks-companies/


Comment